Poll of the Week: Are You Ready for Meaningful Use Attestation Period?
Starting April 18, physicians and hospitals that have taken steps to become meaningful users of electronic health records can start proving they’ve met the criteria. This attestation period allows users to then qualify for the EHR incentive payments under Medicare.
Physicians must meet these meaningful-use criteria for 90 consecutive days to cash in on the incentives.
More than 90 percent of radiologists are considered eligible professionals for the meaningful use program, so they could receive up to $44,000 over five years for implementing and using the technology.
Is your practice planning to attest to being meaningful users of an EHR?
Vote here, and tell us about your experiences meeting the criteria.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
